Header Logo

Connection

BRYAN K KEE to Tumor Suppressor Protein p53

Back to Details
This is a "connection" page, showing publications BRYAN K KEE has written about Tumor Suppressor Protein p53.
BRYAN K KEE
Connection Strength
0.051
Tumor Suppressor Protein p53
  1. Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. Ann Oncol. 2015 May; 26(5):1012-1018.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.